Combination of Chidamide and Fulvestrant for HR+/HER2- Breast Cancer That Has Failed Previous CDK4/6 i Adjuvant Therapy

Clinical trial NCT05806047 · UNKNOWN

Trial details

NCT number: NCT05806047
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hormone Receptor-positive Advanced Breast Cancer

Start date: 2023-05-01
Primary completion: 2024-05-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.